Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Popular Anti-Aging Drug Combo Dasatinib+Quercetin Causes Brain Damage in MiceBrain Health

Popular Anti-Aging Drug Combo Dasatinib+Quercetin Causes Brain Damage in Mice

A drug combination widely used in anti-aging research — dasatinib paired with quercetin — caused serious brain damage in mice, according to new research from the University of Connecticut published in PNAS. The treatment stripped away myelin, the protective coating around nerve fibers essential for brain signaling, in both young and old mice. Younger animals suffered even greater damage. The affected brain cells didn't die but reverted to an immature, less functional state, with signs of disrupted energy metabolism. The corpus callosum, the structure linking the brain's two hemispheres, also deteriorated — changes resembling those seen in chemotherapy-related 'chemo brain.' While the findings are in mice, they raise serious concerns for people self-experimenting with this popular senolytic combination outside clinical supervision.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.